Results 141 to 150 of about 696,413 (247)

Common factors and unique pathways for linkages between HIV/STI prevention and syndemic behaviours in high-risk youth: protocol for a secondary analysis of harmonised data from six clinical trials. [PDF]

BMJ Open
Feldstein Ewing SW, Dash GF, Yang M, Hudson KA, Chung T.   +4 more
europepmc   +1 more source

Clinical Pharmacology Quality Assurance Program for Global HIV and Co‐Infection Drug Development

Clinical Pharmacology &Therapeutics, EarlyView.
When the acquired immunodeficiency syndrome emerged in the 1980s, the United States National Institutes of Health established research networks to conduct clinical trials with the pharmaceutical industry to identify effective antiretroviral therapeutics.
Robin DiFrancesco, Troy D. Wood, Raymond Cha, Jill S. Hochreiter, Susan L. Rosenkranz, Mona Farhad, Kyle R. Whitson, Connor E. Gould, Lauren E. Hill, Linda L. Hale, Philip H. Lindhorst, Diala Ghazal, Charlene R. Taylor, Madiha Quraishi, Suzanne M. Siminski, Yoninah Cramer, Heather L. Sprenger, Gene D. Morse   +17 more
wiley   +1 more source

Integrating HIV services in an era of global change. [PDF]

J Int AIDS Soc
Ratevosian J, Bekker LG, Eakle R, Baral S, Cepeda J, Dugas L, Dybul M, Alleyne G, Eholie SP, Esom K, Grimsrud A, Havlir D, Kamarulzaman A, Kasaie P, Kazatchkine M, Kilonzo N, Klag M, Klein M, Lewin S, Luo C, Makofane K, Martin N, Mayer K, Millett G, Ntusi N, Pace L, Piot P, Poniatowski B, Daskalakis D, Pozniak A, Quinn T, Reynolds C, Rockstroh J, Sippel S, Spire B, Starrs A, Strathdee S, Schechter M, Thomson N, Vickerman P, Weir B, Beyrer C.   +41 more
europepmc   +1 more source

HIV Returns

American Journal of Public Health, 2003
openaire   +3 more sources

Advancing Pharmacometrics in Africa: Insights and Perspectives From the 2025 Pharmacometrics Africa Conference

Clinical Pharmacology &Therapeutics, EarlyView.
Pharmacometrics (PMX) in Africa has transitioned from foundational capacity‐building to job creation, scientific leadership, regulatory influence, and health innovation. To accelerate this progress, the 2025 Pharmacometrics Africa Conference (PMXAC‐2025) convened key stakeholders to consolidate the continental PMX community, review progress in local ...
Babatunde Ayodeji Adeagbo, Innocent Gerald Asiimwe, Linda Chaba, Aida N. Kawuma, Francis Williams Ojara, Ochuko Maureen Orherhe, Simon Peter Asiimwe, Veshni Pillay‐Fuentes Lorente, Sharon Sawe, Cassius M. Phogole, Catriona Waitt, Samer Mouksassi, Goonaseelan (Colin) Pillai   +12 more
wiley   +1 more source

Availability, acceptability and adoption of decision aids for HIV prevention and contraception for young people: a scoping review protocol. [PDF]

BMJ Open
Kabonga I, Kuguyo O, Mancitshana L, Chidhanguro K, Munhenzva S, Masiyambiri F, Ruhode N, Mangenah C, Sibanda E.   +8 more
europepmc   +1 more source

Safety, Pharmacokinetics, and Dose Recommendations for Nirmatrelvir/Ritonavir in Individuals with Mild to Moderate COVID‐19 and Severe Renal Impairment

Clinical Pharmacology &Therapeutics, EarlyView.
Patients with severe renal impairment and COVID‐19 are at high risk for severe disease and death. Nirmatrelvir/ritonavir, an antiviral therapy for COVID‐19, is eliminated by renal excretion and can accumulate in patients with severe renal impairment.
Jacqueline Gerhart, Candace R. Bramson, Michelle Goulding, Haihong Shi, Olayide Oladoyinbo, Phylinda L. S. Chan, Sunring Chime, Jennifer Hammond   +7 more
wiley   +1 more source

Navigating the Data Gaps of Ageing Among Women Living With HIV. [PDF]

J Int AIDS Soc
Sabin CA, Chandiwana N, Avihingsanon A, Policek N.   +3 more
europepmc   +1 more source

Who Will Protect the Children?

Annals of the Child Neurology Society, EarlyView.
William D. Graf, Leon G. Epstein
wiley   +1 more source

Patient‐ and Clinician‐Related Factors Associated With the Reduction in Opioid Use Among Adults With Chronic Non‐Cancer Pain: A Systematic Review

Clinical Pharmacology &Therapeutics, EarlyView.
Despite known risks, opioids are widely used for chronic non‐cancer pain (CNCP). Clinical guidelines now recommend deprescribing, but factors predicting success are poorly understood. This systematic review aimed to identify clinician and patient factors associated with attaining successful opioid dose reduction or discontinuation in adults with CNCP ...
Alessandra C. Marcelo, Sarah N. Hilmer, David J. Hunter, Stephanie Mathieson, Riyaas Mohamed, Leo Li, Natalie Fung, Anthony Yue, Manuela L. Ferreira   +8 more
wiley   +1 more source